Deucravacitinib

Deucravacitinib is a selective, allosteric TYK2 inhibitor that blocks IL-12, IL-23 and type I interferon signalling, approved for moderate-to-severe plaque psoriasis and distinguishing itself from JAK inhibitors through its pseudokinase-domain binding mechanism. Simson Pharma's Deucravacitinib reference standard and impurities support analytical development for this novel dermatology target.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Deucravacitinib Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Deucravacitinib
Deucravacitinib Impurity 2
Deucravacitinib Impurity 10
Deucravacitinib Impurity 11
Deucravacitinib Impurity 6
Deucravacitinib Impurity 1
Deucravacitinib Impurity 14
Deucravacitinib Impurity 19
Deucravacitinib Impurity 16
Deucravacitinib Impurity 30
Deucravacitinib Impurity 31
4-Chloro-3-pyridazinecarboxylic acid
Deucravacitinib Impurity 32
Deucravacitinib Impurity 33
Deucravacitinib Impurity 35
Deucravacitinib Impurity 36
Deucravacitinib Impurity 37
Deucravacitinib Impurity 38
Deucravacitinib Impurity 40
Deucravacitinib Impurity 41
Deucravacitinib Impurity 42
4-chloro-6-hydroxypyridazine-3-carboxylic acid
Deucravacitinib Nitroso Impurity 1
Deucravacitinib Impurity 5
Deucravacitinib Impurity 8
Deucravacitinib Impurity 3
Deucravacitinib Impurity 4
Deucravacitinib Dimer Impurity
Deucravacitinib Impurity 13
Deucravacitinib Impurity 9
Deucravacitinib Impurity 15

Isotope Labelled Compounds

Deucravacitinib Impurity 7
Deucravacitinib-13C-D3
Deucravacitinib D3
Deucravacitinib Impurity 12
Deucravacitinib Impurity D3
Deucravacitinib Impurity D6
6-Hydroxy-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
Deucravacitinib Desmethyl Impurity D3
Deucravacitinib Impurity 39
N-Nitroso Deucravacitinib D3
Deucravacitinib N-Oxide Impurity
Deucravacitinib Dimer Impurity 1